Health & Life Sciences

Overview

As a stakeholder in the health and life sciences industry, you work every day to improve human health and enhance patient care. Our national health and life sciences industry team partners with you to advance your objectives. We understand how changing business models, disruptive technologies and increased data security challenges, among other developments, impact your organization, and we work to help you overcome challenges and seize opportunities in this continuously evolving landscape. Whether we are collaborating with a pharmaceutical or medical device manufacturer to guide a new product through the development and approval life cycle or helping health care providers implement their strategic objectives, we provide business-minded solutions to address your most pressing challenges. Our team handles major strategic transactions; represents clients in high-stakes governmental investigations; negotiates cost-saving outsourcing arrangements, IP licenses, software and AI agreements, and research and collaboration agreements; and executes public policy and government affairs strategies for health care, life sciences and patient advocacy organizations. Our professionals include former in-house counsel at health systems and global pharmaceutical and device companies, former congressional and federal agency health policy specialists, and Department of Justice attorneys.

Health & Life Sciences

Overview

Health & Life Sciences Sectors

Insights & Events

Latest

Navigating FDA Regulatory and Litigation Risks With Al-Enabled Medical Devices and Non-Device Software: A Landscape Analysis for Medical Product Counsel

The European Union’s Digital Omnibus and Its Impact on Artificial Intelligence

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Earned Settlement — Reshaping the UK’s Settlement System

EPA Proposes Revisions to Toxic Substances Control Act’s PFAS Reporting Rule — Adds Several Reporting Exemptions

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

Faegre Drinker Wins Trial for Surmodics in High-Profile Merger Challenge Against FTC

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

Faegre Drinker Launches Cross-Service National Security Team

Insights

Navigating FDA Regulatory and Litigation Risks With Al-Enabled Medical Devices and Non-Device Software: A Landscape Analysis for Medical Product Counsel

The European Union’s Digital Omnibus and Its Impact on Artificial Intelligence

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Earned Settlement — Reshaping the UK’s Settlement System

EPA Proposes Revisions to Toxic Substances Control Act’s PFAS Reporting Rule — Adds Several Reporting Exemptions

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

SCOTUS Weighs Trump Administration’s Tariff Authority Under IEEPA; Pharma and Device AI; and More

California’s Frontier Artificial Intelligence Act & More Developments

Libby Baney Comments on Uncertainty in Prescription Drug Market With the Washington Post

FDA Launches Dashboard to Provide Access to Real-Time Adverse Event Data for Cosmetics

Events

Past Events

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

Privacy and Genetic Data

Acquisitions and Divestitures: Perspectives on Buying and Selling Assets

2025 IAIR Technical Development Series Workshop

News

Faegre Drinker Wins Trial for Surmodics in High-Profile Merger Challenge Against FTC

Faegre Drinker Launches Cross-Service National Security Team

Molly Madden Receives 2025 Young Alumni Award From DePauw University

Faegre Drinker Attorneys & Product Liability & Mass Torts Group Recognized in LMG Life Sciences Rankings

Public Company and Corporate Governance Advisor Angie Snavely Rejoins Faegre Drinker as Partner in Minneapolis

Claire Nilson, Abilio Jaribu Shortlisted for 2025 Expatriate Management and Mobility Awards

Faegre Drinker Welcomes Jared Hershberg to Corporate Practice in New York

Jonathan Keller and Helen Tuttle Recognized in 2025 New Jersey Legal Awards

Erica MacDonald Named a 2025 ‘Top Women in Law’ Honoree by Minnesota Lawyer

Kate Sherburne Named a 2025 ‘Notable Partners in Law’ Honoree by Twin Cities Business

Related Legal Services

Experience

Our Experience

Surmodics Inc. Agrees to $627M Acquisition by GTCR

Mineralys Therapeutics, Inc. Enters into $100M ATM Equity Offering Sales Agreement

Cook Medical Litigates National MDL Involving IVC Filter

Elevance Health Enters Strategic Partnership to Advance Primary Care Delivery

Faegre Drinker Represents Miromatrix Medical Inc. in Sale of Company to United Therapeutics Corporation

TT Capital Partners Purchases All Equity Interests of Cantata Health Solutions

Meet The Team

Meet The Full Health & Life Sciences Team

Mary Devlin Capizzi

Patrick S. Cross

David F. Abernethy

Jessica C. Abrahams

Reed Abrahamson

Alison M. Agnew

Nicholas B. Alford

Andrew Anderson

Josh Anderson

Lynne Anne Anderson

Emilija Andrulyte

Nicholas R. Arens

Chemaine A. Athias-Williams

Maddie Augustus

Abdullah M. Azkalany

Brian M. Balduzzi

Alison J. Baldwin

Peter W. Baldwin

Ian J. Bambrick

Libby Baney Burstein

Lauren J.F. Barta

Thomas J. Barton

Michael N. Baxter

Tricia A. Beckmann

Clark A. Belanger